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Abstract
Background: The importance of staying active instead of bed rest has been acknowledged in the management of
musculoskeletal disorders (MSDs). This emphasizes the potential benefits of adjusting work to fit the employee's
remaining work ability. Despite part-time sick leave being an official option in many countries, its effectiveness has not
been studied yet. We have designed a randomized controlled study to assess the health effects of early part-time sick
leave compared to conventional full-day sick leave. Our hypothesis is that if work time is temporarily reduced and work
load adjusted at the early stages of disability, employees with MSDs will have less disability days and faster return to
regular work duties than employees on a conventional sick leave.
Methods/Design: The study population will consist of 600 employees, who seek medical advice from an occupational
physician due to musculoskeletal pain. The inclusion requires that they have not been on a sick leave for longer than 14
days prior to the visit. Based on the physician's judgement, the severity of the symptoms must indicate a need for
conventional sick leave, but the employee is considered to be able to work part-time without any additional risk. Half of
the employees are randomly allocated to part-time sick leave group and their work time is reduced by 40–60%, whereas
in the control group work load is totally eliminated with conventional sick leave. The main outcomes are the number of
days from the initial visit to return to regular work activities, and the total number of sick leave days during 12 and 24
months of follow-up. The costs and benefits as well as the feasibility of early part-time sick leave will also be evaluated.
Conclusion: This is the first randomised trial to our knowledge on the effectiveness of early part-time sick leave
compared to conventional full-time sick leave in the management of MSDs. The data collection continues until 2011, but
preliminary results on the feasibility of part-time sick leave will be available already in 2008. The increased knowledge
will assist in better decision making process regarding the management of disability related to MSDs.
Trial Registration: International Standard Randomised Controlled Trial Number Register, register number
ISRCTN30911719
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Background
Evidence is increasing on the importance of staying active
instead of bed rest in the management of musculoskeletal
disorders (MSDs) and related disability [1-4]. It has been
recommended that total absence from work due to non-
specific back pain should be avoided because of its possi-
ble delaying effects on recovery [5]. In reducing absence
from work due to MSDs or other pain-related conditions,
workplace-based return-to-work interventions have
shown to be effective [6]. The evidence is particularly
strong for offers to accommodate work during recovery
and contacts between healthcare provider and the work-
place.
In a Finnish survey, employees with health problems were
asked to assess their ability to work prior to visiting an
occupational health (OH) physician [7]. The results
showed that employees with MSDs report partial work
ability almost twice as often as complete inability to work
(28% vs. 16%). In the same survey, both employees with
MSDs and their physicians often regarded work-related
interventions as potentially beneficial to improve recov-
ery. The importance of these interventions is further sup-
ported by the evidence on the significance of work-related
factors in the aetiology of MSDs [8].
Employees with partial work ability could be encouraged
to stay at work instead of taking sick leave. It requires,
however, flexible systems to adjust work load in order to
accommodate the employee until the disability has
improved. Part-time sick leave system in Finland enables
the employee to work 40–60% of the daily working time
but only after the full-time sick leave has lasted for almost
three months. In most cases, part-time sick leave is eco-
nomically more rewarding than total absence from work
since, in addition to the salary for the worked hours, the
Social Insurance Institution provides the employee a
monetary compensation, which is half of that for full-time
sick leave. So far, part-time sick leave has been used, how-
ever, less than expected.
In some other countries (e.g., Sweden, Norway, Den-
mark), taking part-time sick leave is allowed without any
preceding full-time sickness absence. Yet, the effectiveness
of part-time sick leave has been poorly studied. A Norwe-
gian cluster-randomised study on "active sick leave"
(return to adjusted work supported by social security after
conventional sick leave had lasted 16 days or more)
showed no beneficial effects, partly because part-time sick
leave system was so seldom used [9]. Users' contentment
seems to be, however, high; 92% of employees on part-
time sick leave in a Swedish survey were satisfied with the
arrangement [10]. Two-thirds of those on full-time sick
leave considered part-time sick leave as a potentially good
alternative for them. Yet, some disadvantages have also
been detected: a Swedish study with a follow-up of 1.5
years found that part-time sick leaves tended to last longer
than conventional sick leaves [11]. The authors concluded
that the effectiveness of part-time sick leave should be
studied in a randomized setting.
This randomized controlled study was designed to assess
the health-related and economical effects of early part-
time sick-leave compared to conventional sick leave in
employees with MSDs.
Methods/Design
Identification and eligibility of study participants
The study will be performed in several OH units of
medium sized and large private or public enterprises, in
which the employees are known to be exposed to physi-
cally strenuous or static work tasks (Figure 1). Employees
who seek medical advice primarily due to musculoskeletal
pain in the neck or shoulder region, back, or upper or
lower extremities are eligible to the study. The symptoms
and related disability must warrant prescription of full-
time sick leave according to the current practice, but the
physician considers the employee to be able to work part-
time without the risk of the health condition to deterio-
rate. Table 1 shows the inclusion and exclusion criteria.
Interventions
During the initial visit, the OH physician will inform the
employee about the study and its aims. If the employee
agrees to participate, informed consent will be signed. It
includes a permission to contact the supervisor, preferably
during the same visit, in order to verify whether the work-
related arrangements for part-time sick leave are feasible,
in case the employee is allocated to the intervention
group. If the supervisor disagrees, the employee will be
excluded from the trial.
Once the agreements from the employee and the supervi-
sor have been obtained and before the randomisation has
occurred, the physician will determine the length of the
sickness absence based on symptoms (Table 2), clinical
findings [12,13] and background information (Table 3).
If the employee is allocated to part-time sick leave (inter-
vention group), daily work load will be reduced by
restricting work time. Also, if necessary, remaining work
tasks will be modified so that working should be possible
despite the symptoms. In the control group, work load
will be eliminated with full-time sick leave. Both groups
will receive appropriate medical advice, and the need for
medical treatments and a control visit will be determined
as usual.
In the following day after the initial visit, those allocated
to part-time sick leave will return to work for 40 to 60% of
their regular working hours. They are asked to give theirBMC Musculoskeletal Disorders 2008, 9:23 http://www.biomedcentral.com/1471-2474/9/23
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supervisor a statement from the physician indicating the
duration of part-time sick leave, what kind of work loads
are allowed and which are not recommended, and if any
additional work adjustments are needed. If the reduction
of work time cannot be organised on a daily basis, the
employee may work every second day for the whole day
and every second day stay at home.
When the sick leave is over, employees in both groups
return to regular work. Those who are unable to resume
regular work activities will be re-evaluated by an OH phy-
sician, who can prescribe either full-time sick leave or con-
tinue part-time sick leave, according to the physician's
clinical judgement. The length of sick leave will be deter-
mined as usual.
If the employee in the part-time sick leave group needs
full-time sick leave, part-time sick leave cannot be applied
again after full-time sick leave has ended. Return to part-
time sick leave is possible in a situation when the health
problem relapses within one month after the employee
has returned to regular work. The total maximum length
of the part-time sick leave is two months. Participation in
the study intervention does not affect the employee's right
to general social security benefits. Neither does it have any
financial effect to the employee, because he or she receives
the same compensation (regular salary) during part-time
and full-time sick leave. The employer will start receiving
compensation after the sick leave has lasted for 10 work-
ing days.
Objectives
Musculoskeletal symptoms typically deteriorate during
the work day and towards the end of the work week, and
they resolve during break, night rest and weekend [14].
Our hypothesis to be tested in the current study is that
employees whose work time is temporarily reduced and
work load adjusted during early stage of disability will
have less disability days and faster return to regular work
duties than employees on conventional sick leave.
Outcomes
The main outcomes are the number of days from the ini-
tial visit to the return to regular work activities and the
total number of part- and full-time sick leave days during
one- and two-year follow-up. Other outcomes are changes
in symptoms as well as in self-assessed functioning during
follow-up [15-17].
Study design Figure 1
Study design.
Company A Company B
Employee with MSD seeking
medical advice from physician
at Occupational Health Unit 
Company C
Assessment for eligibility, informed consent
Agreement with supervisor 
Randomization
Intervention group (n=300)
(part-time sick leave,
work adjustments) 
Internet-based questionnaire at baseline and after 1, 3, 8, 12 and 52 weeks
Data on visits to occupational health physician
and sickness absence after 1 and 2 years 
from register of Occupational Health Unit 
Control group (n=300)
(full-time sick leave) BMC Musculoskeletal Disorders 2008, 9:23 http://www.biomedcentral.com/1471-2474/9/23
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Data on self-assessed workload will be collected after the
initial visit and during part-time sick leave in order to rec-
ognise physically strenuous work tasks relevant to MSDs
[18,19], as well as to list the work adjustments made dur-
ing the part-time sick leave. This will be included in an
internet based questionnaire together with the symptoms
and background variables [20-25]. The questionnaire will
be sent to the employees immediately after recruitment
and at one, three, eight, 12 and 52 weeks. Those without
access to internet will be telephone-interviewed by a
researcher. Also, the supervisors in both groups will be
interviewed by phone after the employee has returned to
work.
Participating employees, their supervisors, OH personnel,
human resources management, as well as occupational
safety and trade union representatives will be interviewed,
and the feasibility of early part-time sick leave will be eval-
uated based on the qualitative information collected in
the interviews. From those employees, who decline to par-
ticipate, only information on age and gender will be col-
lected. They will also be offered a possibility to provide
the main reason for not participating. This can be done
with an anonymous questionnaire that can be returned in
a closed envelope directly to the researchers. The reason
for a negative response from the supervisor is also docu-
mented.
The follow-up is extended to two years with the purpose
of detecting the possible longer-lasting effects on e.g. ill-
ness behaviour. One and two years after the initial visit,
the dates and diagnoses of all sickness absences (includ-
ing those prescribed outside OH services) will be collected
from the OH units.
Patient enrolment started in January 2008 and it is
planned to last until July 2009. Follow-up of the last par-
ticipants will finish two years later in 2011. Based on the
pilot study, however, preliminary results on the feasibility
of early part-time sick leave will be available already in
2008.
Economic evaluation
Costs and benefits to the employee, employer and society
will be estimated in both study groups. Costs due to lost
working time will be analysed separately taking into
account the compensation to the employer during full- or
part-time sick leave. Data on costs of the used health serv-
ices, medications, and medical aids (due to the main
Table 2: Health-related variables inquired at baseline and during follow-up
Outcome Measure
Main reason for the visit (at baseline) Localisation and characteristics of pain
Pain intensity Scale from 0 to 10
Interference with work activities Scale from 0 to 10
Interference with sleeping Scale from 0 to 10
Self-assessed functioning Oswestry Back questionnaire [15] Quick DASH (Disabilities of the Arm, Shoulder and Hand) [16] COAT 
(Comprehensive Osteoarthritis Test) for lower extremities [17]
Productivity at work Quantity and Quality of work [26]
Adjustments at work (during follow-up) Description of change in physical work load (structured and open questions)
Table 1: Eligibility of the participants
Inclusion criteria
- 18 to 60 years of age
- permanent or long-term employment (30 hours or more per 
week)
- no sick leave or other absence exceeding two weeks during the 
preceding month
- not more than 30 days on sick leave due to any health problem 
during three preceding months
- employee is not listed for any surgery that requires more than 
one week of sickness absence
- no plan for longer absence from work during 12 months after 
enrollment
- an employee can be enrolled only once
General exclusion criteria
- acute infections
- major accidental injury
- active inflammatory arthritis
- suspected occupational injury or disease
- malignant tumour diagnosed or treated during the preceding year
- severe mental disorder
- pregnancy
- severe pain (> 7 on a scale from 0 to 10)
- pain interferes with sleep severely (> 7 on scale from 0 to 10)
Pain area specific exclusion criteria
Back region:
- muscle weakness in the lower extremities related to back pain
- positive straight-leg-raising test
- pain-related trunk list
- painful spasm of the back when bending forward
Neck and shoulder region:
- muscle weakness in the upper extremities related to the pain
- head compression or movements induce radiating pain below 
elbow level
- painful torticollis
Shoulder and upper extremity regions:
- muscle weakness related to the pain
- severe pain in movements interfering with most functions
Lower extremities:
- pain prevents walkingBMC Musculoskeletal Disorders 2008, 9:23 http://www.biomedcentral.com/1471-2474/9/23
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health problem) will also be collected. In addition, the
analysis will include the compensation of the lost work
input using stand-ins (salary, training time) or overtime
(performed by the colleagues of the study subjects), as
well as the time the supervisor used for work arrange-
ments.
The non-monetary benefits will be studied based on self-
assessed productivity at work [26], as well as the reduction
of pain and disability measured on a scale from 0 to 10
(Table 2). If there is a difference between the groups in the
outcome measurements, a cost effectiveness analysis will
be performed dividing the costs by the units of difference
in the outcome. If there is no significant difference
between the study groups in any of the health related out-
comes, the analysis of total costs in both groups will be
applied in making the final conclusions.
Sample size
A 10% difference between intervention and control group
in the proportions of employees returning to regular work
at a given time point will be considered significant. The
power of the study is aimed at 80%, and the level of sig-
nificance at 0.05. Assuming a drop-out rate of 10–15%,
600 employees will be needed for the study (300 in both
groups). Using previous information on sickness absen-
teeism in Finnish enterprises, and to ensure a sufficient
pool of subjects, we will include in the study base a suffi-
cient number of companies employing up to 30 000 per-
sons.
Randomisation
Employees will be randomised using sealed opaque enve-
lopes, which contain information on the allocated group.
The allocation has been performed at the Finnish Institute
of Occupational Health using a random number genera-
tor and block randomisation in order to obtain equal size
of intervention and control group for the participating
physicians.
Blinding
Due to practical and ethical reasons neither the employee
nor the physician will be blinded to group assignment
during the initial visit. Allocation is also open to the two
interviewers and to the other possible physicians during
later visits.
Statistical methods
A survival analysis will be used to study the time to return
to work in the intervention and control group. The
amount of sick leave days will be analysed at 12 and 24
months, and the associations between the outcomes and
background variables will be analysed using general linear
models. In addition, the change in symptoms and disabil-
ity indices will be studied at various time points using
general linear models for repeated measurements.
Subgroup analyses will be performed in relation to patient
compliance, type of work, adequacy of work adjustments,
previous sick leaves, pain characteristics (such as localisa-
tion, duration), and level of disability at baseline. All anal-
yses will be made based on an intention-to-treat principle.
Ethics
The Coordinating Ethics Committee of Hospital District
of Helsinki and Uusimaa has granted approval for this
study.
Clinical Trial Register
This study has been registered at International Standard
Randomised Controlled Trial Number Register, register
number ISRCTN30911719
Discussion
The target of this intervention is to adjust work (both
work time and demands) to accommodate the disabled
employee so that he or she can continue working during
recovery from a MSD. As pointed out by Durand et al [27],
Table 3: Explanatory variables measured at baseline
Assessments by physician
Physical examination Standardised protocol [12, 13]
Weight Self-reported
Height Self-reported
Health-related background 
information
Diabetes, cardiovascular diseases Interview by physician
Previous sick leaves OH data base
Depression Questionnaire [20]
Quality of life EQ-5D [21]
Physical work load factors
Handling of loads, repetitive 
movements, use of hand tools, 
awkward postures at work
Questionnaire [18, 19]
Background variables
Company Questionnaire
Occupation
Main work tasks
Education
Job seniority
Work hours
Commuting time
Age
Gender
Marital status
Smoking
Alcohol consumption
Physical exercise
Psychosocial risk factors Adapted from Copenhagen 
Psychosocial Questionnaire [22]
Fear avoidance Questionnaire [23]
Procedural and relational justice Questionnaire [24]
Effort-reward imbalance Questionnaire [25]BMC Musculoskeletal Disorders 2008, 9:23 http://www.biomedcentral.com/1471-2474/9/23
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in this type of intervention work becomes an object of the
intervention itself raising various methodological chal-
lenges. In addition to the medical judgement by the phy-
sician, the intervention requires actions and decisions
made by the employee, supervisor, colleagues and
employer – each with their own values, objectives, inter-
ests, and training [28].
Sickness absence is usually considered as a consequence
of a health disorder rather than its treatment and, there-
fore, in most studies, it has been used as an outcome
measure. In this trial, however, the mode of sick leave
(part- or full-time) is used as an intervention to affect the
outcome, i.e., the quantity of sick leave (number of sick
leave days). The potential benefit of the intervention, i.e.,
the difference in the total number of full- or part-time sick
leave days between the intervention and control group,
will arise either from the employee's decision to return to
regular work earlier than recommended by the physician,
or from the need for additional part- or full-time sick leave
during the follow-up period.
It is essential in this intervention that the physician deter-
mines the length of the disability before allocation, and
adheres to this when prescribing either part- or full-time
sick leave. This is to avoid bias that might occur if the
length of the sick leave is determined differently for part-
and full-time sick leave. The risk for bias concerns also the
possible control visit, during which the allocation to fur-
ther part- or full-time sick leave is again open to both the
physician and the employee. Inappropriately timed return
to regular work in either group should, however, show in
secondary outcomes, such as pain, functional status,
employee satisfaction and costs.
Despite the extensive amount of quantitative data col-
lected in this trial on individual, ergonomic, psychosocial
and economic factors, we do not have the means to quan-
tify all the aspects of the arrangements made at the work-
places during part-time sick leave. Acknowledging the
potential effect of this contextual process on the outcome
of the intervention, we aim to collect all relevant qualita-
tive data during the study from the employee and the
supervisor.
This is the first randomized controlled trial to our knowl-
edge to investigate the effectiveness of early part-time sick
leave in comparison to conventional full-time sick leave
in musculoskeletal symptoms. The results and the
increased knowledge will assist in better decision making
process regarding the management of disability related to
MSDs.
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